Of note, no significant dose correlation was found for changes in the serum prolactin concentration, and no associated hyperprolactinemia was reported after patients received 1-week HSK21542, contrary to the actions of nalfurafine hydrochloride (Kumada et al., 2017). This evidence concerns the gene PRL and hyperprolactinemia.